SK

Sukanya Kariki

Active Director Director DIN 08816818
DIN 08816818 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Sukanya Kariki

Data last updated:

Sukanya Kariki is a Director at Oak Vance Life Sciences Private Limited (since 2020). The company operates in Pharma. Oak Vance Life Sciences Private Limited reported revenue of ₹1.69 Cr (FY 2025).

DIN 08816818
Primary Designation Director
Industry Pharma
First Appointment 11 Nov 2020
Oldest Company Age 5 yrs
Largest company Oak Vance Life Sciences Private Limited · ₹1.69 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Nov 20202020₹1.69 Cr (FY 2025)Active

Board colleagues of Sukanya Kariki

Directorship timeline

Open interactive timeline →
Oak Vance Life Sciences Private Limited
Premium access

Shareholding and investment profile for Sukanya Kariki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sukanya Kariki

Sukanya Kariki currently holds 1 directorship: Oak Vance Life Sciences Private Limited (Director, since 11 Nov 2020, revenue ₹1.69 Cr (FY 2025)).

Sukanya Kariki was first appointed on 11 Nov 2020 as Director at Oak Vance Life Sciences Private Limited.

The current boards of Sukanya Kariki's companies include Sasivardhan Reddy Kasireddy (Oak Vance Life Sciences Private Limited), Trinath Tummepalli (Oak Vance Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available